Additional file 2 of Biomarker testing for advanced lung cancer by next-generation sequencing; a valid method to achieve a comprehensive glimpse at mutational landscape

Additional file 2. Pattern and distribution of the TP53 mutations in the cohort according to (A) Mutation type (B) Mutation effect on TP53 protein sequence (C) Exon/ Intron distribution (D) Functional effect (E) SIFT prediction (IARC TP53 Database). (N = 100, lung cancer subjects).